Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Knoll Takeover Value Hinges On Outlook For D2E7 Rheumatoid Arthritis Agent

Nov 20 2000

• By The Pink Sheet

Related Content

Bristol Rx Expansion Plans Include Biologics Manufacturing

Oct 02 2000

Genelabs/Watson Aslera Lupus Deal Includes $30.5 Mil. In Up-Front Payments

Nov 20 2000

Knoll Considering Segard Plans; Sepsis Study Shows Small Mortality Benefit

Jul 10 2000

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window